The Aim of this study is to Review the timing of intervention which will provide the Best Outcome in Hypothyroidism in Pregnancy. Hypothyroid pregnant women are appropriately managed with regular antenatal checkup and thyroxine therapy during pregnancy, a good maternal and fetal outcome can be achieved and congenital cretinism and other neuro developmental sequele in the offspring can be averted.
Introduction:
Thyroid hormones have profound variation during the life span and are associated with severe adverse health impacts. 1 Pregnancy, as an important reproductive event, has a profound but reversible effect on the thyroid gland and its functions. Pregnancy is actually a state of excessive thyroid stimulation leading to an increase in thyroid size by 10% in iodide sufficient areas and 20-40% in iodide deficient regions. Furthermore following the physiological and hormonal changes caused by pregnancy and human chorionic gonadotropin (HCG) the production of thyroxin (T4) and triiodothyronine (T3) increase up to 50% leading to 50% increase in a woman's daily iodide need, while Thyroidstimulating hormone (TSH) levels are decreased, especially in first trimester. 2 In an iodide sufficient area, these thyroid adaptations during pregnancy are well tolerated, as stored inner thyroid iodide is enough; however in iodide deficient areas, these physiological adaptations lead to significant changes during pregnancy. 3 Thyroid function testing in pregnancy is an area of concern for pregnant women, doctors and laboratories. Most anxiety relates to the diagnosis of hypothyroidism, the most common thyroid disease in our community and the focus of this review. Approximately 15-20% of young Australian women have thyroid autoantibodies and 2-3% have subclinical hypothyroidism in pregnancy. History, examination findings on each antenatal visit, on admission and during the stay in hospital and investigations in chronological order were taken on the predesigned Performa by the Chief Investigator herself.
In the hypothyroid patients, besides the routine antenatal profile and ultrasonography, thyroid function tests served as the guiding investigations in the management of pregnancy. The TSH and FT4 levels 'were done in the hypothyroid patients on their first antenatal visit. According to the values, thyroxine dose was revised. Later on .in the pregnancy, TSH and FT4 levels were done every 6-8 weeks or whenever required with respect 'to the signs and symptoms of the patient, fetal growth parameters and any dose revision.
In the euthyroid patients, besides the routine antenatal profile and ultrasonography examination, TSH and FT4 levels were done anytime between 16-20 weeks of gestation.
Whenever the patient was admitted to the hospital, either in labour or for any complication, she was managed appropriately. The basic guidelines for management included maintaining euthyroid state of tile mother (in cases) and assuring a good maternal and fetal outcome.
After delivery the cord blood samples of neonate was sent for TSH and FT4 estimation and according to the initial values, babies were given thyroxine replacement therapy and followed-up later. (  17  8  19  17  6  8  (   50  6  17  19  8   2 The difference between the two groups is not statistically significant The difference between the two groups is not statistically significant
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Discussion
The table shows that 32% of the hypothyroid patients had a history of spontaneous abortion while 24% of euthyroid patients had such history. The difference between the two groups was .not statistically significant though Abalovich et al. 5 and Davidson et al 6 have' found an increased rate of spontaneous abortions in hypothyroidism. K Buckshee et al found that 32% of hypothyroid patients had history of abortion.
Alex F. Muller and Arie Berghout 7 study Netherlands shoed spontaneous pregnancy loss in 31% cases of hypothyroidism since the fetus expresses paternal MHC molecule adaptations.
There was a significant increase in the incidence of operative intervention in the hypothyroid pregnant women. While 48% of the hypothyroid patients underwent LSCS, 24% of the euthyroid patients delivered by LSCS. K Buckshee et al report operative intervention in 25.4 % cases 7 .
Conclusion
Hypothyroid pregnant women are appropriately managed with regular antenatal checkup and thyroxine therapy during pregnancy, a good maternal and fetal outcome can be achieved and congenital cretinism and other neuro developmental sequele in the offspring can be averted.
